Sorafenib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT00253578 · COMPLETED
Trial details
- NCT number
- NCT00253578
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2007-11-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.